pharmaphorum

JUNE 15, 2021

These expectations carry over into healthcare, where patients and healthcare professionals leverage a wide array of channels to meet their needs and feel frustrated when their expectations are not smoothly met. As Mark Wehde, Chair, Mayo Clinic Division of Engineering, explains: “Healthcare is shifting from a traditional hospital?centric

Big Data 52

Big Data Nurses Genome Genomics 52

The Pharma Data

NOVEMBER 23, 2021

Our scientific moxie, combined with the breadth of our portfolio and channel, also provides a unique occasion to develop combination rules that aim to ameliorate the lives of cases indeed further. About Roche Roche is a global colonist in medicinals and diagnostics concentrated on advancing wisdom to ameliorate people’s lives.

Antibody 52

Antibody In-Vitro Development Genome 52

XTalks

JANUARY 17, 2024

These databases also typically miss critical information like genomic and molecular data. These are designed from the very beginning to capture comprehensive information, including not just clinical but also social, economic and genomic/molecular factors.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

pharmaphorum

JULY 9, 2021

He is also executive sponsor for the customer excellence (CX) capability community spanning areas such as key account management (KAM), omni-channel engagement (OCE), insights & analytics (I&A) and leadership & development (L&D). Adam is Takeda’s designated representative on the EFPIA Patient Access Committee (PAC).

Development 122

Development Genome Genomics Engineer 122

The Pharma Data

NOVEMBER 26, 2021

Sanofi’s investment will support Owkin’s development and thing to grow the world’s leading histology and genomic cancer database from top oncology centers. This cooperation will help accelerate our ambitious oncology program as we advance a rich channel of drugs to address unmet case requirements.”. Co-Founder and CEO at Owkin. “

Development 52

Development Scientist Medicine Drugs 52

The Pharma Data

NOVEMBER 18, 2021

Sanofi’s investment will support Owkin’s development and thing to grow the world’s leading histology and genomic cancer database from top oncology centers. This cooperation will help accelerate our ambitious oncology program as we advance a rich channel of drugs to address unmet case requirements.”. Co-Founder and CEO at Owkin. “

Development 52

Development Scientist Medicine Drugs 52

The Pharma Data

SEPTEMBER 16, 2020

LBA15 (Oral), Saturday, 19 September, (Channel 1) 16:20-16:32 CEST. LBA11 (Oral), Sunday, 20 September, (Channel 3) 12:30-12:42 CEST. LBA16 (Oral), Saturday, 19 September, (Channel 1) 16:32-16:44 CEST. LBA4 (Presidential symposium II), Sunday, 20 September, (Channel 1) 19:02-19:14 CEST. HER2-positive breast cancer.

HR 52

HR Medicine Hormones Trials 52

XTalks

DECEMBER 11, 2023

The notable growth owes itself to heightened sales of prescription gammaCore products across all channels, alongside revenue generated from the nonprescription performance TAC-STIM and Truvaga wellness products. A noteworthy facet of Access Bio’s approach is its extensive global collaboration. Its CAGR is 76 percent. million to $15.0

Production 110

Production Sales In-Vitro Development 110

Drug Discovery World

FEBRUARY 21, 2023

While most biotechnology organisations are comfortable leveraging text/image-based platforms like Twitter, Instagram, and LinkedIn, fewer currently leverage video-focused channels like TikTok, Instagram Reels, and YouTube.

Marketing 52

Marketing Branding Gene Therapy DNA 52

Pharma Marketing Network

DECEMBER 21, 2020

Almost two decades after the human genome was sequenced, a trickle of new genetic medicines (i.e., These smaller parcels of more easily digestible information can help to surface key themes and messages, prevent the audience from feeling overwhelmed, and are also an important component of outreach via social media channels.

Genetics 52

Genetics Medicine Gene Therapy Marketing 52

The Pharma Data

SEPTEMBER 28, 2021

These new respiratory test panels run on the cobas omni Utility Channel to be used with the widely available, high-volume cobas® 6800/8800 Systems, which have proven to bring reliable results quickly to satisfy the urgent demand for patient testing during the COVID-19 pandemic. Source link: [link].

Marketing 52

Marketing In-Vitro DNA Bacteria 52

XTalks

SEPTEMBER 12, 2023

Biomedical Research and Technologies: Get access to the most recent biomedical research news from both industry and academia, including preclinical studies and technological breakthroughs in genomics, single cell analysis, proteomics, metabolomics and much more.

Life Science 105

Life Science Branding Clinical Trials Clinical Trials 105

The Pharma Data

JUNE 26, 2021

Roche has existing distribution channels established to ship Actemra/RoActemra to hospitals across the United States. In recent years, Roche has invested in genomic profiling and real-world data partnerships and has become an industry-leading partner for medical insights. About the Actemra/RoActemra COVID-19 Clinical Trial Programme.

Clinical Trials 40

Clinical Trials Clinical Trials In-Vitro Antibody 40

pharmaphorum

SEPTEMBER 2, 2022

Beyond personalising content, creating a tailored channel experience is also vitally important. In R&D, we are leveraging data in terms of proteomics and genomics and plan to utilise AI and machine learning to maximise our research opportunities.

Doctors 59

Doctors Doctor Production Development 59

XTalks

MARCH 25, 2021

Prior to joining Xtalks, Nabulsi worked at Discovery Channel on shows that include The Daily Planet and Mighty Cruise Ships. She has a Master of Journalism from Ryerson University and completed her undergraduate degree at York University with an Honors in Communication Studies and Marketing.

Life Science 105

Life Science HR Clinical Trials Clinical Trials 105

pharmaphorum

MAY 5, 2021

It is not all about COVID, though, and Mr Hancock said it was important to channel new learnings and thinking into tackling pre-existing health challenges. “We need to get to a world where we take our tests at home if you test positive, you take your antivirals at home: that is the next national mission.”.

Life Science 61

Life Science Manufacturing Vaccination Vaccine 61

Drug Discovery World

JANUARY 12, 2023

The genome is the blueprint for life, consisting of genes made up of thousands of pairs of DNA bases. CRISPR allows researchers to target and edit specific genes in order to better understand the genome, human diseases and the effects of specific mutations.

Gene Editing 98

Gene Editing Gene Drugs In-Vivo 98

pharmaphorum

JANUARY 4, 2023

In the case of immediate rights of access, particularly where this would be inappropriate or unethical, such as informing a patient via an electronic channel about a diagnosis of an incurable disease instead of providing this information during a face-to-face consultation.

Regulation 98

Regulation Research Development Genome 98

The Pharma Data

NOVEMBER 17, 2021

The companies will work GSK’s moxie in functional genomics and combine their capabilities in CRISPR webbing and artificial intelligence to identifyanti-coronavirus composites that target cellular host genes. They will also apply their concerted moxie to probe SARS-CoV-2 and other coronavirus vaccines. Source link: [link].

Antibody 52

Antibody In-Vitro Vaccination Vaccine 52

Drug Discovery World

AUGUST 18, 2022

As can limitations on the number of excitation wavelengths and available detection channels. With up to 27 fluorescence channels, you can handle much more complex assays and get more done in each single well. Depend on Bio-Rad for tools, technologies, and expertise to enable cellular, genomic, and proteomic analysis. .

Antibody 52

Antibody Drugs Life Science Genome 52

Drug Discovery World

NOVEMBER 8, 2023

Harriman will present ‘Discovering functional modulators of the ion channel Kv1.3 Jae Seong Lee, PhD, Associate Professor, Applied Chemistry & Biological Engineering, Ajou University, on: “Genome-wide virus-free CRISPR screening platform for identifying novel engineering targets in mammalian cells”.

Antibody 64

Antibody Engineer Protein Scientist 64

The Pharma Data

AUGUST 6, 2020

Revenues remained consistent on a pro forma basis, as sales were estimated to be negatively impacted by approximately $600 million due mainly to COVID-19 related channel inventory work downs from the first quarter, as well as lower demand resulting from reduced new patient starts and fewer patient visits to physicians in the pandemic.

Production 52

Production Branding Marketing Licensing 52

Pfizer

NOVEMBER 2, 2022

This is reminiscent of influenza, another respiratory disease that requires repeated vaccinations due to its genomic instability resulting in modifications of the surface protein hemagglutinin. Influenza accounts for up to 12,000 to 52,000 deaths in the United States every year iv and equally concerning numbers in the European Union v.

Vaccination 85

Vaccination Vaccine Clinical Trials Clinical Trials 85

Pharmaceutical Technology

JUNE 21, 2023

These span multiple structural classes and target several classes of proteins, including cytokines, enzymes, G protein-coupled receptors (GPCRs), and ion channels. Empress benefits from a wealth of clinical data, and recent advances in genomics, artificial intelligence (AI) and synthetic biology.

Development 130

Development Drugs Protein Life Science 130